SHARON AGACITE: Open Payments
NPI 1508190380 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 8 payments from 7 companies in 2025. Trend: 2023 $135 · 2024 $23 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $44 |
| ABBVIE INC. | 1 | $33 |
| Novo Nordisk Inc | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| LNHC, Inc | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: MOUNJARO, UBRELVY, Ozempic, AIRSUPRA, ZELSUVMI, GARDASIL 9, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
